[go: up one dir, main page]

ES8700940A1 - Improvements relating to the treatment control and prevention of rhinovirus infections. - Google Patents

Improvements relating to the treatment control and prevention of rhinovirus infections.

Info

Publication number
ES8700940A1
ES8700940A1 ES549671A ES549671A ES8700940A1 ES 8700940 A1 ES8700940 A1 ES 8700940A1 ES 549671 A ES549671 A ES 549671A ES 549671 A ES549671 A ES 549671A ES 8700940 A1 ES8700940 A1 ES 8700940A1
Authority
ES
Spain
Prior art keywords
prevention
improvements relating
treatment control
rhinovirus infections
rhinovirus
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES549671A
Other languages
Spanish (es)
Other versions
ES549671A0 (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
TYRRELL DAVID ARTH
Original Assignee
TYRRELL DAVID ARTH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB848430883A external-priority patent/GB8430883D0/en
Priority claimed from GB858511658A external-priority patent/GB8511658D0/en
Application filed by TYRRELL DAVID ARTH filed Critical TYRRELL DAVID ARTH
Publication of ES549671A0 publication Critical patent/ES549671A0/en
Publication of ES8700940A1 publication Critical patent/ES8700940A1/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Bidet-Like Cleaning Device And Other Flush Toilet Accessories (AREA)

Abstract

The synergistic combination of a non-interferon antiviral substance active against rhinoviruses and an interferon for simultaneous, sequential or separate use in the treatment or prevention of rhinovirus infection.
ES549671A 1984-12-06 1985-12-06 Improvements relating to the treatment control and prevention of rhinovirus infections. Expired ES8700940A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB848430883A GB8430883D0 (en) 1984-12-06 1984-12-06 Treatment/control of rhinoviruses
GB858511658A GB8511658D0 (en) 1985-05-08 1985-05-08 Treatment control/prevention of rhino-virus infection

Publications (2)

Publication Number Publication Date
ES549671A0 ES549671A0 (en) 1986-11-16
ES8700940A1 true ES8700940A1 (en) 1986-11-16

Family

ID=26288545

Family Applications (1)

Application Number Title Priority Date Filing Date
ES549671A Expired ES8700940A1 (en) 1984-12-06 1985-12-06 Improvements relating to the treatment control and prevention of rhinovirus infections.

Country Status (6)

Country Link
EP (1) EP0207116A1 (en)
AU (1) AU5234586A (en)
ES (1) ES8700940A1 (en)
GB (1) GB2168608A (en)
NO (1) NO863165L (en)
WO (1) WO1986003412A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4820515A (en) * 1982-12-13 1989-04-11 Texas A&M University System Method of using interferon in low dosage to regulate appetite and efficiency of food utilization
US4820514A (en) * 1985-12-30 1989-04-11 Texas A&M University System Low dosage of interferon to enhance vaccine efficiency
GB8813032D0 (en) * 1988-06-02 1988-07-06 Boehringer Ingelheim Int Antiviral pharmaceutical composition

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0080032A3 (en) * 1981-11-20 1985-11-13 Enzo Biochem, Inc. Pharmaceutical preparation for treating herpetic lesions

Also Published As

Publication number Publication date
GB8530152D0 (en) 1986-01-15
WO1986003412A1 (en) 1986-06-19
ES549671A0 (en) 1986-11-16
NO863165D0 (en) 1986-08-05
EP0207116A1 (en) 1987-01-07
AU5234586A (en) 1986-07-01
NO863165L (en) 1986-08-05
GB2168608A (en) 1986-06-25

Similar Documents

Publication Publication Date Title
IT8522574A0 (en) PHARMACEUTICAL COMPOSITION AND PROCEDURE FOR TREATING THE HUMAN BODY WITH IT.
FR2615394B1 (en) USE OF CERTAIN 17-CETOSTEROIDS, POSSIBLY WITH AN IMMUNOMODULATOR AND / OR ANTIVIRAL AGENT, TO MANUFACTURE A MEDICAMENT FOR THE TREATMENT AND PREVENTION OF RETROVIRAL INFECTIONS
ZA921660B (en) Antiviral nucleoside combination
NZ309217A (en) Ribavirin and interferon alpha for the treatment of hepatitis C
PT741577E (en) USING THE ALPHA INTERFERENCE SUBTYPE 8 IN THE PREPARATION OF MEDICINES FOR TREATING FIGURE VIRAL INFECTIONS
ES2155834T3 (en) PROCEDURE FOR THE PROCESSING OF INJURIES OR CELLULAR DECREASES.
MY106263A (en) Method for the treatment or prevention of intrinsically aged skin with retinoids
GR3019514T3 (en) Pharmaceutical preparation for the treatment of prolonged coagulation time
ATE26216T1 (en) COMPOSITIONS CONTAINING INTERFERON AND THEIR THERAPEUTIC USE.
OA09917A (en) Compounds for use in treating HIV infection
EP0313654A4 (en) Drug for prophylaxis and treatment of hepatopathy.
ES8700940A1 (en) Improvements relating to the treatment control and prevention of rhinovirus infections.
DE3569673D1 (en) Use of saccharomyces yeasts for the manufacture of a medicament for preventing or treating pseudo-membranous colitis
ZA968783B (en) Flupirtine usage
FR2361109A1 (en) ANTHELMINTHIC MEDICINES
IL117998A0 (en) Use of leukemia inhibitory factor and endothelin antagonists
EP1240899A3 (en) Modulation of Th1/Th2 Cytokine expression by Ribavirin and Ribavirin analogs in actived T-Lymphocytes for treating HCV infections
EP0656116A4 (en) Methods for monitoring effectiveness of interferon therapy in individuals with hcv infections.
ES2103811T3 (en) ANTIVIRAL THERAPY.
FI952018A0 (en) Use of BHAP compounds in combination with other non-nukeocide transcriptase inhibitors for the treatment of HIV infection
JPS55113721A (en) Immunity regulator
EP1143981A4 (en) Treatment and prevention of hiv and other viral infections
IL107818A0 (en) Method of treating viral infections by conjunctive therapy with acyclovir-like compounds and a 2'-vinyl substituted nucleoside analog
IL154299A0 (en) Treatment of hepatitis c with thymosin, interferon and ribavirin
OA09771A (en) Asphodelus composition for increasing white blood cell count.